血管内治疗时代院内缺血性卒中再灌注治疗的趋势
2018年较2008年院内卒中比例及再灌注治疗率均升高,但院内卒中较院外卒中再灌注延迟更长、功能预后更差。
要点
- 院内卒中占全部卒中出院比例从2008年2.7%升至2018年3.5%。
- 院内卒中静脉溶栓率从9.1%升至19.1%,血管内治疗率从2.5%升至6.4%。
- 院内卒中较院外卒中从识别到影像和溶栓时间更长,功能预后更差。
核心结论
- 院内卒中报告率和再灌注治疗使用率随时间增加。
- 院内卒中较院外卒中再灌注延迟更长且功能预后更差。
主要发现
- 2018年较2008年院内卒中占所有卒中出院比例更高(3.5% vs 2.7%;P < .001)。
- 2018年较2008年院内卒中静脉溶栓使用率更高(19.1% vs 9.1%;P < .001),血管内治疗使用率更高(6.4% vs 2.5%;P < .001)。
- 院内卒中较院外卒中从识别到颅脑影像时间更长(中位数33 vs 16分钟;P < .001),到溶栓推注时间更长(81 vs 60分钟;P < .001)。
- 调整分析中,院内卒中接受静脉溶栓者出院时独立行走可能性更低(aOR 0.78;95% CI 0.74-0.82;P < .001),死亡或出院至临终关怀可能性更高(aOR 1.39;95% CI 1.29-1.50;P < .001)。
临床怎么用
- 应关注院内卒中识别与再灌注流程的及时性,以减少治疗延迟。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: A significant proportion of acute ischemic strokes occur while patients are hospitalized. Limited contemporary data exist on the utilization rates of intravenous thrombolysis or endovascular therapy for in-hospital stroke. OBJECTIVE: To use a national registry to examine temporal trends in the use of intravenous and endovascular reperfusion therapies for treatment of in-hospital stroke. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study analyzed data from 267 956 patients who underwent reperfusion therapy for stroke with in-hospital or out-of-hospital onset reported in the Get With the Guidelines-Stroke national registry from January 2008 to September 2018. EXPOSURES: In-hospital onset vs out-of-hospital onset of stroke symptoms. MAIN OUTCOMES AND MEASURES: Temporal trends in the use of reperfusion therapy, process measures of quality, and the association between functional outcomes and key patient characteristics, comorbidities, and treatments. RESULTS: Of 67 493 patients with in-hospital stroke onset, this study observed increased rates of vascular risk factors (standardized mean difference >10%) but no significant differences in age or sex in patients undergoing intravenous thrombolysis only (mean [interquartile range {IQR}] age, 72 [80-62] y; 53.2% female) or those undergoing endovascular therapy (mean [IQR] age, 69 [59-79] y; 49.8% female). Of these patients, 10 481 (15.5%) received intravenous thrombolysis and 2494 (3.7%) underwent endovascular therapy. Compared with 2008, in 2018 the proportion of in-hospital stroke among all stroke hospital discharges was higher (3.5% vs 2.7%; P < .001), as was use of intravenous thrombolysis (19.1% vs 9.1%; P < .001) and endovascular therapy (6.4% vs 2.5%; P < .001) in patients with in-hospital stroke, with a significant increase in endovascular therapy in mid-2015 (P < .001). Compared with patients who received intravenous thrombolysis for out-of-hospital stroke onset, those with in-hospital onset were associated with longer median (IQR) times from stroke recognition to cranial imaging (33 [18-60] vs 16 [9-26] minutes; P < .001) and to thrombolysis bolus (81 [52-125] vs 60 [45-84] minutes; P < .001). In adjusted analyses, patients with in-hospital stroke onset who were treated with intravenous thrombolysis were less likely to ambulate independently at discharge (adjusted odds ratio, 0.78; 95% CI, 0.74-0.82; P < .001) and were more likely to die or to be discharged to hospice (adjusted odds ratio, 1.39; 95% CI, 1.29-1.50; P < .001) than patients with out-of-hospital onset who also received intravenous thrombolysis treatment. Comparisons among patients treated with endovascular therapy yielded similar findings. CONCLUSIONS AND RELEVANCE: In this cohort study, in-hospital stroke onset was increasingly reported and treated with reperfusion therapy. Compared with out-of-hospital stroke onset, in-hospital onset was associated with longer delays to reperfusion and worse functional outcomes, highlighting opportunities to further care for patients with in-hospital stroke onset.
引用
- Akbik F, Xu H, Xian Y, et al. Trends in Reperfusion Therapy for In-Hospital Ischemic Stroke in the Endovascular Therapy Era. JAMA Neurol. 2020. PMID: 32955582. doi:10.1001/jamaneurol.2020.3362
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。